Tue, Sep 2, 2014, 3:41 AM EDT - U.S. Markets open in 5 hrs 49 mins

Recent

% | $
Quotes you view appear here for quick access.

Guided Therapeutics, Inc Message Board

  • cytomotw cytomotw Jul 18, 2013 6:47 AM Flag

    GTHP Continues to Await FDA

    The technology seems to be amazing but sales continue to be non-existant in countries where it is being marketed. Is the world's system inexorably tied to the FDA? This stock should be over $1 on the tech alone. GLTA

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I agree. The reality is very different. GTHP is dead money until it gets FDA approval. The secondary a couple months ago really hurt the stock. However, the main issue is that we continue to wait for the FDA. FDA is about 2 months late but the technology is impressive. Already approved in Canada and Europe. Company should be at break even (cash flow) late this year. As a result, I do not expect additional dilution. Insiders got warrants and can buy at 68 cents where we have support. Ton of sellers above 70 cents not sure why. I think the risk/reward favor longs. However, be warned.... until FDA you are looking at dead money. The problem is FDA can be tomorrow or 12 months from now.

 
GTHP.OB
0.00(0.00%)

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Exelixis, Inc.
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT
Splunk, Inc.
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT